Sort by
Refine Your Search
-
models will be used to unravel niche-driven leukemia initiation mechanisms. Ectopic humanized in vivo BM-AML organoids will be used to validate the identified therapeutic targets. The post-doctoral fellow
-
. To achieve our objectives, we will use cutting-edge technologies (CITE-seq, RNA-seq, Ribo-seq) and combine analysis in readily available relevant cellular models of cancer-experienced T cells, syngeneic mouse
Searches related to model driven engineering
Enter an email to receive alerts for model-driven-engineering positions